| Roles of SM22α in cellular plasticity and vascular diseases. | |
| | |
MedLine Citation:
|
PMID: 23030444 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
SM22α is a shape change and transformation sensitive 22 kDa actin-binding protein of the calponin family. It is ubiquitous to vascular and visceral smooth muscle, and is an early marker of smooth muscle differentiation. It is also present in fibroblasts, and some epithelium. SM22α may be involved in calcium-independent smooth muscle contraction. Recent evidence suggests that disruption of SM22α induces vascular inflammation and is involved in osteochondrogenesis in arterial diseases. This is consistent with activation of NF-κB signaling, where NF-κB activity is upregulated in vascular injury. High expression of SM22α inhibits cell proliferation in VSMCs and in injured arteries. SM22α acts as a tumor suppressor. Loss of its expression is an early event in cell transformation and the development of some tumors, coinciding with cellular plasticity. |
| | |
Authors:
|
L- H Dong; P Lv; M Han |
Related Documents
:
|
17716954 - Effects of heptanol and carbenoxolone on noradrenaline induced contractions in guinea p... 21938374 - Evaluation of in vivo rotator cuff muscle function after acute and chronic detachment o... 6861584 - In vitro effects of pancreatic polypeptide and motilin on contractility of human gallbl... 6883444 - The long-term influence of decentralisation or preganglionic hypogastric nerve stimulat... 22863354 - Schwann cells migrate along axons in the absence of gdnf signaling. 16756054 - Morphometric data of normal sural nerve in thai adults. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-10-01 |
Journal Detail:
|
Title: Cardiovascular & hematological disorders drug targets Volume: - ISSN: 2212-4063 ISO Abbreviation: Cardiovasc Hematol Disord Drug Targets Publication Date: 2012 Oct |
Date Detail:
|
Created Date: 2012-10-3 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101269160 Medline TA: Cardiovasc Hematol Disord Drug Targets Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Biochemistry and Molecular Biology, Ministry of Education, Hebei Medical University, No. 361, Zhongshan East Road, Shijiazhuang, 050017, China. hanmei@hebmu.edu.cn. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Accumulation of elements by edible mushroom species: Part I. Problem of trace element toxicity in mu...
Next Document: Platelets in Thrombosis and Hemostasis: Old Topic with New Mechanisms.